on a mobile?
vTap
    Loading...
 
 
Video
The pharmaceuticals giant takes a hit on declining sales of cholesterol fighter Lipitor, reports CNBC's Mike Huckman
1m 26s |
7 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Atorvastatin
Pfizer
CNBC
Go to Feed to see what's new!
share
keep
 
 
...icials from the companies testified about Pfizer’s ads for Lipitor featuring Dr. Robert Jarvik, Merck/Schering-Plough’s "Food and Family" ads for Vytorin, and Johnson and Johnson’s ads for ...
3h 57m 0s |
6 months ago
C-SPAN
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Pfizer
Bart Stupak
Washington, D.C.
White House
Go to Feed to see what's new!
share
keep
 
 
1125
...t in Delaware court, reports CNBC-TV18. The patent infringement relates to Lipitor and Caduet. Pfizer’s move is aimed at delaying Ranbaxy's generic Lipitor launch. Ranbaxy's generic Lipitor will ...
8 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Atorvastatin
Caduet
Pfizer
Ranbaxy Laboratories
CNBC-TV18
CNBC
Go to Feed to see what's new!
share
keep
 
 
Merrill reports more write-downs, Sallie Mae disappoints, IBM's profits surge.
7 months ago
Forbes
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
EBay
Merrill Lynch
Pfizer
IBM
SLM Corporation
Go to Feed to see what's new!
share
keep
 
 
Investors get back at it after Wednesday's rally, with Merrill Lynch and Google on the docket.
7 months ago
Forbes
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Merrill Lynch
Pfizer
IBM
Google
J. P. Morgan
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
21015
US Patent and Trademark Office, or PTO, has rejected Pfizer's application for re-issue of the Lipitor patent, reports CNBC-TV18. The US PTO's decision is in favour of Ranbaxy. The Indian pharma major plans to launch a Lipitor generic version In US fr...
7 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Atorvastatin
Ranbaxy Laboratories
Pfizer
Pharmaceutical company
United States Patent and Trademark Office
CNBC-TV18
CNBC
Reissue
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use